Can antitumor platinum compounds be effective against Candida albicans? - A screening assay using disk diffusion method [3]

K. Chandrasekar; J. H. Shyla; R. Malathi

doi:10.1128/jcm.38.10.3905-3905.2000

Can antitumor platinum compounds be effective against Candida albicans? - A screening assay using disk diffusion method [3]

K. Chandrasekar, J. H. Shyla, R. Malathi

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	3905
Number of pages	1
Journal	Journal of Clinical Microbiology
Volume	38
Issue number	10
DOIs	https://doi.org/10.1128/jcm.38.10.3905-3905.2000
State	Published - 2000
Externally published	Yes

ASJC Scopus Subject Areas

Microbiology (medical)

Access to Document

10.1128/jcm.38.10.3905-3905.2000

OpenUrl availability

Full text

Cite this

@article{a7cc60f7db784708a7c6b5204a376f38,

title = "Can antitumor platinum compounds be effective against Candida albicans? - A screening assay using disk diffusion method [3]",

author = "K. Chandrasekar and Shyla, {J. H.} and R. Malathi",

note = "For the first time, we report that the antitumor drug cisplatin exhibits antifungal activity against Candida albicans, a disease-causing pathogen among cancer patients ( 4). The efficacy of this drug against C. albicans combined with the high demand for development of antifungal agents, especially in immunocompromised patients, prompted us to undertake a screening assay for different platinum compounds against C.",

year = "2000",

doi = "10.1128/jcm.38.10.3905-3905.2000",

language = "English",

volume = "38",

pages = "3905",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

number = "10",

}

TY - JOUR

T1 - Can antitumor platinum compounds be effective against Candida albicans? - A screening assay using disk diffusion method [3]

AU - Chandrasekar, K.

AU - Shyla, J. H.

AU - Malathi, R.

N1 - For the first time, we report that the antitumor drug cisplatin exhibits antifungal activity against Candida albicans, a disease-causing pathogen among cancer patients ( 4). The efficacy of this drug against C. albicans combined with the high demand for development of antifungal agents, especially in immunocompromised patients, prompted us to undertake a screening assay for different platinum compounds against C.

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0033775548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033775548&partnerID=8YFLogxK

U2 - 10.1128/jcm.38.10.3905-3905.2000

DO - 10.1128/jcm.38.10.3905-3905.2000

M3 - Letter

SN - 0095-1137

VL - 38

SP - 3905

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

IS - 10

ER -

Can antitumor platinum compounds be effective against Candida albicans? - A screening assay using disk diffusion method [3]

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this